137 related articles for article (PubMed ID: 19486257)
21. Epidemiological trends of hepatocellular carcinoma in Austria.
Pinter M; Hucke F; Zielonke N; Trauner M; Sieghart W; Peck-Radosavljevic M
Dig Dis; 2014; 32(6):664-9. PubMed ID: 25376282
[TBL] [Abstract][Full Text] [Related]
22. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
[TBL] [Abstract][Full Text] [Related]
23. Multiple primary malignant tumors in patients with hepatocellular carcinoma. A review of 29 patients.
de Pangher Manzini V; Calucci F; Terpin MM; Loru F; Brollo A; Ramani L; Zuch C; Bianchi C
Tumori; 1996; 82(3):245-8. PubMed ID: 8693603
[TBL] [Abstract][Full Text] [Related]
24. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States.
Al-Shamsi HO; Abdel-Wahab R; Hassan MM; Shalaby AS; Dahbour I; Lacin S; Mahvash A; Odisio BC; Murthy R; Avritscher R; Abdelsalam ME; Rashid A; Vauthey JN; Aloia TA; Conrad C; Chun YS; Krishnan S; Das P; Koay EJ; Amin HM; Yao JC; Kaseb AO
Oncology; 2017; 93(4):233-242. PubMed ID: 28683459
[TBL] [Abstract][Full Text] [Related]
25. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
26. Childhood liver tumors in Argentina: Incidence trend and survival by treatment center. A report from the national pediatric cancer registry, ROHA network 2000-2015.
Moreno F; Rose A; Chaplin MA; Cipolla MC; García Lombardi M; Nana M; Cervio G; Halac E; Viso M; Ayarzabal V; Bosaleh A; Liberto D; Sarabia E; Rizzi A; Morici M; Streitenberger P; de Dávila MTG
Pediatr Blood Cancer; 2020 Nov; 67(11):e28583. PubMed ID: 32737960
[TBL] [Abstract][Full Text] [Related]
27. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S
Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297
[TBL] [Abstract][Full Text] [Related]
28. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the surgical outcomes in patients with synchronous versus metachronous multiple hepatocellular carcinoma.
Midorikawa Y; Takayama T; Higaki T; Aramaki O; Teramoto K; Yoshida N; Mitsuka Y; Tsuji S
Biosci Trends; 2021 Jan; 14(6):415-421. PubMed ID: 32999134
[TBL] [Abstract][Full Text] [Related]
30. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
Liu KJ; Lv YX; Niu YM; Bu Y
Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
[TBL] [Abstract][Full Text] [Related]
32. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.
Arase Y; Kobayashi M; Suzuki F; Suzuki Y; Kawamura Y; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Kobayashi T
Hepatology; 2013 Mar; 57(3):964-73. PubMed ID: 22991257
[TBL] [Abstract][Full Text] [Related]
33. Second primary cancers in patients with hepatocellular carcinoma: a nationwide cohort study in Taiwan.
Wu WC; Chen YT; Hwang CY; Su CW; Li SY; Chen TJ; Liu CJ; Kao WY; Chao Y; Lin HC; Wu JC
Liver Int; 2013 Apr; 33(4):616-23. PubMed ID: 23331767
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
35. The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study.
Mao K; Yan Y; Zhang J; Wang J; Wang R; Ling X; Liu Y; Lau WY; Jiang S; Liu J; Xiao Z
Cancer Med; 2018 Sep; 7(9):4475-4484. PubMed ID: 30117307
[TBL] [Abstract][Full Text] [Related]
36. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
37. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
38. Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database.
Cha B; Yu JH; Jin YJ; Suh YJ; Lee JW
Sci Rep; 2020 May; 10(1):8347. PubMed ID: 32433488
[TBL] [Abstract][Full Text] [Related]
39. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.
Uka K; Aikata H; Takaki S; Shirakawa H; Jeong SC; Yamashina K; Hiramatsu A; Kodama H; Takahashi S; Chayama K
World J Gastroenterol; 2007 Jan; 13(3):414-20. PubMed ID: 17230611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]